Cargando…
Ovarian cancer modulates the immunosuppressive function of CD11b(+)Gr1(+) myeloid cells via glutamine metabolism
OBJECTIVE: Immature CD11b (+) Gr1(+) myeloid cells that acquire immunosuppressive capability, also known as myeloid-derived suppressor cells (MDSCs), are a heterogeneous population of cells that regulate immune responses. Our study's objective was to elucidate the role of ovarian cancer microen...
Autores principales: | Udumula, Mary P., Sakr, Sharif, Dar, Sajad, Alvero, Ayesha B., Ali-Fehmi, Rouba, Abdulfatah, Eman, Li, Jing, Jiang, Jun, Tang, Amy, Buekers, Thomas, Morris, Robert, Munkarah, Adnan, Giri, Shailendra, Rattan, Ramandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267600/ https://www.ncbi.nlm.nih.gov/pubmed/34144215 http://dx.doi.org/10.1016/j.molmet.2021.101272 |
Ejemplares similares
-
Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017) -
Dietary energy balance modulates ovarian cancer progression and metastasis
por: Al-Wahab, Zaid, et al.
Publicado: (2014) -
Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
por: Rattan, Ramandeep, et al.
Publicado: (2012) -
Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
por: Tebbe, Calvin, et al.
Publicado: (2014) -
Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
por: Udumula, Mary P., et al.
Publicado: (2022)